Hospitals and healthcare businesses should assess how patient leads are generated, how agencies are paid and whether any payments could be interpreted as referral commissions. Transparent contracts, clearly defined marketing deliverables, patient-data protection and appropriate professional conduct are important when structuring healthcare marketing campaigns. Any claim about specific NMC Guidelines 2026 provisions should be checked against the official notification before being treated as a confirmed legal requirement.
Healthcare marketing differs from marketing in other industries because it involves patient trust, medical ethics, sensitive health information and decisions about treatment. Arrangements involving lead-generation fees, referral commissions, influencers, healthcare aggregators or patient-acquisition contracts may raise ethical and compliance concerns depending on their structure. Hospitals, doctors and marketing agencies should ensure that their agreements prioritise ethical patient communication, privacy, transparency and applicable medical regulations.
NMC Guidelines 2026: Is Pay-Per-Patient Marketing Now a Compliance Risk?
Healthcare marketing is changing, and hospitals need to pay close attention to how they structure their digital marketing contracts. An agency may help a hospital improve search visibility, manage advertising and maintain its website. However, paying an intermediary for individual patient referrals raises different regulatory concerns.
India's National Medical Commission (NMC) guidelines dated 6 October 2026 address ethical advertising and public communication by hospitals, medical institutions and registered medical practitioners. Paragraphs 8.1(vii) and 8.1(viii) are particularly relevant to referral commissions, lead-generation fees and marketing arrangements linked to patient procurement.
For hospital administrators, doctors, healthcare aggregators and digital marketing agencies, the key issue is understanding what a payment covers and whether it is connected to procuring or referring individual patients.
1. What Do the NMC Guidelines Say About Lead-Generation Fees?
Paragraph 8.1(vii) addresses commissions, rebates, bonuses, gifts, referral fees, lead-generation fees and other consideration connected with referring, recommending or procuring patients, specimens or materials for medical services.
Paragraph 8.1(viii) addresses arrangements with advertising agencies, digital marketing agencies, influencers and online platforms where payment is linked to procuring or referring individual patients.
These provisions are relevant to modern marketing arrangements, including appointment platforms, healthcare aggregators and patient-acquisition contracts.
Three points hospitals should understand
- Payments connected with individual patient procurement or referral require careful regulatory review.
- Hiring a marketing agency does not remove the professional obligations that apply to a doctor or medical institution.
- Even when the payment structure is appropriate, the advertising content and methods used must comply with applicable ethical requirements.
A fixed-fee contract is not automatically compliant, and measuring campaign performance does not, by itself, mean that an agency is being paid to procure patients. The actual services, contract terms and payment triggers matter.
Relevant provisions: Paragraphs 4.4 and 8.1(vii)–(viii).
2. Were Patient-Referral Commissions Already Restricted?
Restrictions on patient-referral commissions predate the October 2026 guidelines. Regulation 6.4.1 of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 addresses gifts, gratuities, commissions and bonuses connected with referring, recommending or procuring patients for medical or surgical treatment.
The 2026 guidelines specifically address contemporary marketing arrangements, including lead-generation fees and agency contracts linked to individual patient procurement.
Patient enquiries may now originate through search advertisements, social media, online directories and appointment-booking platforms. Although the technology has changed, the underlying ethical concern remains: financial incentives should not improperly influence patient referrals or clinical decisions.
Relevant provisions: Regulation 6.4.1 of the 2002 Regulations and paragraphs 8.1(vii)–(viii) of the 2026 guidelines.
3. Is Pay-Per-Patient Marketing a Compliance Risk?
A contract that pays an agency or intermediary for each individual patient it procures or refers raises a direct concern under the new guidelines.
Examples include:
- Paying an agency a fixed amount for every patient referred to a doctor.
- Paying a commission for each patient who undergoes a procedure.
- Giving an agency a percentage of a patient's surgery bill.
- Providing bonuses for reaching a target number of treated patients.
- Paying an intermediary for each patient admitted through a referral network.
These arrangements link compensation to individual patient procurement, referrals or treatment activity. They should be treated as high-priority compliance issues and reviewed by qualified healthcare regulatory counsel.
The legal assessment may depend on the parties involved, the practitioner's role, the contractual terms and the applicable professional and institutional framework.
4. What Is the Difference Between Pay-Per-Lead and Pay-Per-Patient?
The term lead can refer to several different stages in a marketing campaign. It might mean a website enquiry, a form submission, a prospective patient's contact details, a booked appointment or someone who has attended a consultation.
These events should not automatically be treated as legally equivalent.
| Payment arrangement | Practical assessment |
|---|---|
| Fixed monthly website maintenance fee | Generally lower structural risk |
| Fixed SEO management retainer | Generally lower structural risk |
| Fee for producing agreed content | Generally lower structural risk |
| Campaign management fee based on advertising spend | Requires review; not automatically prohibited |
| Fee for each individual enquiry | Requires careful review of the arrangement |
| Fee for each booked patient appointment | High-risk patient-procurement linkage |
| Commission for each completed surgery | Direct patient-procurement concern |
| Percentage of treatment revenue paid to an agency | Direct patient-procurement concern |
This table is a practical risk assessment, not a list of payment models approved by the NMC.
What about Google Ads cost per click?
Digital advertising platforms may charge for clicks or impressions. These advertising metrics are not automatically equivalent to a commission paid to an intermediary for procuring a specific patient.
Similarly, tracking cost per lead internally does not necessarily mean an agency receives a separate fee for each patient enquiry. The contract, payment trigger, campaign content and actual services must be considered together.
5. Can Hospitals Still Hire Digital Marketing Agencies?
Yes. Hospitals can obtain legitimate digital marketing and technical services, provided the activities and commercial arrangements comply with applicable rules.
Common services include:
- Website development and maintenance.
- Technical SEO and website performance improvements.
- Accurate institutional information and search listings.
- Medical content production and educational communication.
- Website accessibility and technical compliance reviews.
- Advertising account administration and campaign reporting.
- Privacy, security and content-governance improvements.
Paying an agency an agreed fee to maintain a website is different from paying a commission for every patient sent for surgery. However, a fixed-fee arrangement does not make prohibited advertisements or endorsements acceptable.
Both the commercial agreement and the communication being published should be reviewed.
Relevant provisions: Paragraphs 4.4, 8.1(ii), 8.1(vii)–(viii) and 8.3.
6. Are Performance Marketing and Patient Acquisition the Same?
Not necessarily. Performance marketing can measure website traffic, search visibility, engagement, enquiries and other campaign results. Patient acquisition refers more specifically to attracting or procuring individuals who may receive healthcare services.
For example, an agency might report that a hospital's orthopaedic information page received 12,000 visits and generated 140 enquiries. This is campaign reporting.
A different contract might require the hospital to pay the agency a separate fee for each of those enquiries. That payment structure requires closer scrutiny because compensation is tied to individual prospective patients.
Calling a payment a performance bonus or marketing incentive does not necessarily change its character if the substance of the arrangement is patient procurement.
7. Is Cost-Per-Appointment Marketing Safer Than Cost-Per-Patient Marketing?
Not automatically. An appointment is different from a completed consultation or treatment, but paying an agency for every appointment it procures for a medical practitioner may still raise concerns under the restrictions on patient procurement and referral.
Consider two arrangements:
- Arrangement A: An agency receives ₹20,000 per month to maintain an appointment-booking system.
- Arrangement B: An agency receives ₹1,000 each time it secures a prospective patient's appointment with a particular doctor.
The first pays for a defined technical service. The second links payment to the procurement of individual appointments. Hospitals should carefully review contracts with booking platforms, telecalling agencies and lead-generation vendors before accepting this type of arrangement.
8. Can Hospitals Pay Agencies a Percentage of Advertising Spend?
A management fee calculated as a percentage of advertising expenditure is not expressly identified in paragraphs 8.1(vii)–(viii) as a prohibited pricing method. It differs from a fee triggered by each individual patient referral.
However, it should not automatically be described as NMC-approved. The underlying marketing activity must comply with applicable advertising restrictions, and the payment structure must not disguise compensation for patient procurement.
A clearly documented service fee can make the commercial arrangement easier to understand and distinguish from referral-based remuneration. This is a risk-management recommendation, not an express regulatory safe harbour.
9. What About Healthcare Aggregators and Doctor-Booking Platforms?
Healthcare platforms may provide legitimate services such as doctor directories, appointment scheduling, teleconsultation infrastructure, patient-information resources and digital administration tools.
However, their business models vary. A fixed software subscription is not automatically equivalent to a commission for referring individual patients. A directory that presents paid rankings as objective assessments of medical quality raises a separate concern.
Paragraph 9.4 addresses responsibilities of healthcare platforms hosting registered medical practitioners, including ethical advertising and transparency in listing practices. Paragraph 8.1(xii) addresses manipulative reviews, rankings and digital visibility.
Platforms should review their payment models and how doctors and hospitals are presented to users. Paid placement should not mislead patients into believing that commercial payments establish medical superiority.
10. Can Influencers Be Paid to Promote a Hospital?
Influencer arrangements require review of both the payment structure and the content being published.
Paragraph 8.1(viii) addresses arrangements linked to individual patient procurement or referral. Paragraph 8.1(xi) addresses the use of influencers, patients, celebrities and other third parties for prohibited endorsements or promotion of professional services.
A flat influencer fee does not automatically make every promotion acceptable. For example, paying a celebrity to describe a surgeon as the best in the city may raise advertising concerns even if the payment is unrelated to the number of patients generated.
Hospitals should ensure that public communication is accurate and consistent with applicable professional advertising requirements.
11. What About Referrals Between Doctors, Hospitals and Diagnostic Centres?
The concerns are not limited to digital marketing agencies. Paragraph 8.1(vii) addresses consideration connected with referring or procuring patients, specimens or materials for diagnosis, treatment, surgery and other medical services.
Arrangements that warrant review include:
- Payments for directing patients to a particular specialist.
- Commissions for referrals to diagnostic laboratories.
- Payments linked to surgical admissions.
- Financial incentives connected with an individual patient's treatment decision.
Such arrangements should be assessed under the 2026 guidelines, the applicable professional ethics framework and relevant State or institutional requirements. Financial incentives must not compromise independent clinical decisions or patient choice.
12. Can Agencies Continue Reporting Leads and Conversions?
Yes. Measuring campaign performance is not, by itself, prohibited by the patient-procurement fee clauses. Hospitals and agencies can assess whether their legitimate communication and digital services are effective.
Common reporting metrics include:
- Website visitors and organic search impressions.
- Click-through rates and advertising clicks.
- Enquiry-form submissions.
- Aggregate appointment demand.
- Website usability and campaign performance.
- Cost per advertising click.
Reporting must also respect confidentiality and applicable data-protection requirements. Patient names, diagnoses, treatment histories and other identifiable medical information should not be transferred to advertising platforms or agency dashboards unnecessarily.
Hospitals should review access permissions, reporting processes and vendor agreements to ensure that personal information is handled appropriately.
13. Who Is Responsible if a Marketing Agency Publishes Non-Compliant Content?
Paragraph 4.4 is important for hospital management because using an agency, influencer or online platform does not automatically remove a practitioner's or institution's responsibility for content they have authorised, commissioned, sponsored, adopted or knowingly permitted.
Hospitals should not assume that responsibility rests entirely with the agency. Agencies, in turn, should not assume that client approval makes every advertisement permissible.
Hospital responsibilities
- Provide accurate institutional and clinical information.
- Check medical claims before publication.
- Maintain a clear approval process.
- Seek legal advice when an arrangement raises regulatory concerns.
Agency responsibilities
- Deliver the services specified in the contract.
- Avoid misleading advertising and prohibited promotional practices.
- Implement approved corrections accurately.
- Raise potential compliance concerns before publication.
Contractual responsibilities
Agreements should specify the services supplied, payment terms, approval procedures, data access, confidentiality obligations and responsibility for corrective action. Contractual indemnities may allocate commercial risk between parties, but they do not override regulatory obligations.
14. What Should Hospitals Do About Existing Pay-Per-Patient Contracts?
Hospitals should review existing contracts rather than assume that agreements signed before October 2026 are exempt. The guidelines came into force on 6 October 2026, and any applicable transition arrangements should be verified against the official text.
A five-step contract review
- Identify the payment trigger. Determine whether fees are based on services, deliverables, advertising expenditure, enquiries, appointments, referrals, procedures or treatment revenue.
- Examine the procurement link. Establish whether the payment compensates the delivery or referral of individual prospective patients.
- Review the marketing activity. Check whether the campaign involves prohibited testimonials, endorsements, personal promotions or solicitation.
- Check patient-data handling. Identify whether patient information is being shared unnecessarily with vendors or advertising platforms.
- Obtain qualified legal advice. Review questionable clauses and restructure arrangements where required.
Changing the name of a fee does not necessarily change the substance of the arrangement. A payment described as a marketing service charge may still raise concerns if it remains linked to individual patient procurement.
15. What Commercial Models Can Hospitals Consider?
Hospitals can continue to obtain technical, creative and advisory services through clearly defined commercial agreements. Service-based fees may be easier to distinguish from commissions for procuring individual patients.
| Service | Possible billing approach |
|---|---|
| Website development | Fixed project fee |
| Website maintenance | Monthly service retainer |
| Technical SEO | Monthly scope-based fee |
| Medical content production | Fee per agreed deliverable |
| Website compliance assessment | Fixed audit fee |
| Digital accessibility improvements | Project-based fee |
| Advertising account administration | Defined service retainer |
| Analytics and reporting | Fixed management fee |
| Training and content governance | Workshop or advisory fee |
| Compliance monitoring | Recurring service fee |
These are possible commercial structures, not NMC-approved safe harbours. The actual services and advertising activity must comply with the applicable rules, and the payment arrangement must not disguise compensation for patient referrals.
16. Does This Mean Hospitals Can No Longer Measure Business Growth?
No. Hospitals still need to plan capacity, communicate their services, improve patient experience and understand whether their digital presence is effective.
The important distinction is between evaluating legitimate marketing services and paying an intermediary to procure individual patients.
Digital strategy can focus on accurate service information, accessible websites, responsible public education, reliable technical infrastructure and clear institutional communication.
Commercial practices used in retail or other consumer industries should not be adopted automatically in healthcare. Medical decisions involve patient welfare, clinical judgement and professional responsibilities that require additional care.
17. Can Violations Lead to Professional Disciplinary Action?
Paragraph 10 of the October 2026 guidelines describes graduated disciplinary measures for applicable violations by registered medical practitioners. Depending on the circumstances and the governing framework, measures may include warnings, ethics training, censure, monetary penalties and suspension or removal from the professional register for specified periods.
Such consequences are not automatic merely because an allegation has been made. The competent authority must follow applicable law and procedural requirements.
For medical institutions, the relevant clinical-establishment framework and State legislation may also need to be considered. An advertising dispute should not automatically be treated as cancellation of an institutional licence, but referral-based remuneration should not be dismissed as a minor contractual matter either.
Relevant provisions: Paragraphs 10 and 11.
18. Healthcare Marketing Compliance Checklist
| Review question | Action |
|---|---|
| Does the agency receive payment for each patient referred? | Arrange a priority legal review |
| Is payment triggered by procedures or treatment revenue? | Review the procurement link |
| Does the contract pay for individual appointments or enquiries? | Examine the actual payment arrangement |
| Is the fee based on defined services? | Document the deliverables and terms |
| Are invoices linked to individual patient records? | Review remuneration and privacy risks |
| Are influencers paid to generate consultations? | Review both payment and content |
| Are doctor rankings influenced by commercial payments? | Check transparency and applicable restrictions |
| Do advertisements contain patient endorsements? | Review and correct where necessary |
| Are clinical claims checked before publication? | Maintain a documented approval process |
| Is patient information shared unnecessarily with vendors? | Restrict access and review data handling |
| Are contracts signed before October 2026 still active? | Reassess the existing terms |
| Are written marketing approvals maintained? | Establish and document controls |
Hospitals and agencies should apply this checklist to both existing and proposed arrangements. Where a payment may be linked to patient procurement, obtain qualified legal advice before relying on the contract.
19. Conclusion: Healthcare Growth Must Respect Professional Ethics
The October 2026 NMC guidelines highlight the need to distinguish legitimate marketing services from payments connected with procuring or referring individual patients.
Hospitals can invest in accurate information, professional digital services, accessible websites and responsible public communication. Agencies can demonstrate value through technical expertise, quality of work, reliable reporting and clearly defined deliverables.
The commercial arrangement should be transparent, and neither payment structures nor promotional practices should compromise professional independence or patient welfare.
Responsible healthcare marketing builds visibility and credibility without turning individual patient referrals into a commission-based transaction.
Need a Review of Your Hospital's Marketing Arrangements?
Existing digital marketing agreements, appointment-generation arrangements and referral-based payment models may require review in light of the October 2026 guidelines.
STYL Digital Solutions LLP offers preliminary screening of publicly accessible healthcare advertising and communication to identify potential concerns. Contractual remuneration and regulatory questions should be assessed separately by qualified healthcare regulatory counsel.
Call or WhatsApp: +91 95000 99066
Contact: Finney
Founder, STYL Digital Solutions LLP
STYL provides digital strategy, technical reviews and marketing implementation services. Its preliminary screening is not an NMC-authorised certification or a legal opinion. Contractual legal review should be undertaken by appropriately qualified counsel.
Official Regulatory References
- National Medical Commission, Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners, dated 6 October 2026. Refer to paragraphs 4.4, 8.1(ii), 8.1(vii)–(viii), 8.1(xi)–(xii), 8.3 and 9.4. View the cited NMC document.
- Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, particularly Regulation 6.4.1. View the cited regulations.
- National Medical Commission Act, 2019, and applicable State clinical-establishment legislation.
Editorial note: This article provides general regulatory and commercial information and is not a formal legal opinion. The specific provisions, effective date, enforcement mechanisms and any transition arrangements should be checked against the official regulatory text. Hospitals and agencies should obtain qualified legal advice before making decisions about contractual payment structures.